z-logo
Premium
Novel Magnetic‐Luminescent Janus Nanoparticles for Cell Labeling and Tumor Photothermal Therapy
Author(s) -
Wu Qiang,
Lin Yining,
Wo Fangjie,
Yuan Yufeng,
Ouyang Qingling,
Song Jun,
Qu Junle,
Yong KenTye
Publication year - 2017
Publication title -
small
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.785
H-Index - 236
eISSN - 1613-6829
pISSN - 1613-6810
DOI - 10.1002/smll.201701129
Subject(s) - materials science , photothermal therapy , luminescence , nanoparticle , nanomedicine , nanotechnology , cancer cell , biophysics , cancer , medicine , optoelectronics , biology
Abstract Magnetic‐luminescent nanocomposites have multiple uses including multimodal imaging, magnetic targeted drug delivery, and cancer imaging‐guided therapies. In this work, dumbbell‐like MnFe 2 O 4 –NaYF 4 Janus nanoparticles are synthesized via a two‐step thermolysis approach. These synthesized nanoparticles exhibit stability in aqueous solutions and very low cytotoxicity after poly(acryl amide) modification. High cellular uptake efficiency is observed for the folic acid‐conjugated MnFe 2 O 4 –NaYF 4 in human esophagus carcinoma cells (Eca‐109) due to the upconversion luminescence properties as well as the folate targeting potential. The MnFe 2 O 4 –NaYF 4 also strongly absorbs light in the near‐infrared range and rapidly converts to heat energy. It is demonstrated that Eca‐109 cells incubated with MnFe 2 O 4 –NaYF 4 are killed with high efficiency after 808 nm laser irradiation. Furthermore, the growth of tumors in mice (grown from Eca‐109 cells) is highly inhibited by the photothermal effects of MnFe 2 O 4 –NaYF 4 efficiently. Histological analysis reveals no pathological change and inflammatory response in heart, liver, spleen, lung, or kidney. The low toxicity, excellent luminescence, and highly efficient photothermal therapy properties of MnFe 2 O 4 –NaYF 4 Janus nanoparticles illustrated in this work support their vast potential for nanomedicine and cancer therapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here